HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jie Ding Selected Research

NPHS2 protein

12/2017Accelerated podocyte detachment and progressive podocyte loss from glomeruli with age in Alport Syndrome.
5/2006Diversities of podocyte molecular changes induced by different antiproteinuria drugs.
11/2004A novel mutation of NPHS2 identified in a Chinese family.
10/2004Effect of the knockdown of podocin mRNA on nephrin and alpha-actinin in mouse podocyte.
9/2004Key molecular events in puromycin aminonucleoside nephrosis rats.
4/2004[Relationship between podocyte molecule's distribution and expression, foot process morphology and proteinuria].
11/2003Expression of nephrin, podocin, alpha-actinin, and WT1 in children with nephrotic syndrome.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jie Ding Research Topics

Disease

136Neoplasms (Cancer)
10/2022 - 03/2002
42Inflammation (Inflammations)
01/2023 - 01/2009
42Stomach Neoplasms (Stomach Cancer)
08/2022 - 02/2002
31Neoplasm Metastasis (Metastasis)
10/2022 - 07/2005
27Hepatocellular Carcinoma (Hepatoma)
10/2022 - 08/2008
25Hereditary Nephritis (Alport Syndrome)
11/2021 - 04/2004
24Proteinuria
05/2022 - 04/2004
23Wounds and Injuries (Trauma)
01/2022 - 12/2006
18Fibrosis (Cirrhosis)
01/2022 - 04/2002
17Cicatrix (Scar)
01/2023 - 11/2009
17Breast Neoplasms (Breast Cancer)
10/2021 - 01/2012
14Carcinogenesis
10/2022 - 12/2004
14Hypoxia (Hypoxemia)
01/2022 - 12/2011
13Stroke (Strokes)
01/2022 - 02/2011
11Colorectal Neoplasms (Colorectal Cancer)
01/2022 - 09/2015
10Nephrotic Syndrome (Syndrome, Nephrotic)
01/2022 - 09/2003
10Hypertrophic Cicatrix (Hypertrophic Scar)
01/2022 - 05/2011
10Myocardial Infarction
01/2022 - 11/2017
10Lung Neoplasms (Lung Cancer)
01/2022 - 01/2011
10Infections
01/2022 - 06/2008
9Burns
01/2022 - 09/2011
9Colonic Neoplasms (Colon Cancer)
12/2021 - 01/2012
9Carcinoma (Carcinomatosis)
04/2020 - 06/2003
8Hypertension (High Blood Pressure)
11/2022 - 02/2014
8Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
04/2021 - 06/2015
8Ischemic Stroke
01/2021 - 01/2014
8Chronic Kidney Failure (Chronic Renal Failure)
01/2020 - 11/2005
7Prostatic Neoplasms (Prostate Cancer)
05/2022 - 01/2016
7Neuromyelitis Optica (Devic's Disease)
01/2021 - 01/2018
6Glioma (Gliomas)
10/2022 - 01/2016
6Adenoma (Adenomas)
08/2022 - 01/2019
6Necrosis
01/2022 - 12/2011
6Kidney Diseases (Kidney Disease)
01/2019 - 10/2010
5Body Weight (Weight, Body)
06/2022 - 04/2015
5Type 2 Diabetes Mellitus (MODY)
10/2021 - 11/2010
5Uterine Cervical Neoplasms (Cancer of the Cervix)
01/2021 - 08/2010
5Thrombosis (Thrombus)
12/2020 - 01/2012
5Cognitive Dysfunction
01/2019 - 11/2010
5Reperfusion Injury
01/2019 - 03/2009
5Flatulence
09/2017 - 10/2011
4Spinal Cord Injuries (Spinal Cord Injury)
01/2023 - 08/2014

Drug/Important Bio-Agent (IBA)

51Proteins (Proteins, Gene)FDA Link
10/2022 - 04/2004
32MicroRNAs (MicroRNA)IBA
06/2022 - 08/2008
32Biomarkers (Surrogate Marker)IBA
05/2022 - 11/2011
23Pharmaceutical PreparationsIBA
08/2022 - 05/2004
21CollagenIBA
01/2022 - 03/2011
21Messenger RNA (mRNA)IBA
01/2022 - 02/2002
19Biological ProductsIBA
06/2022 - 11/2009
19Long Noncoding RNAIBA
01/2022 - 04/2014
14CytokinesIBA
05/2022 - 11/2009
12DNA (Deoxyribonucleic Acid)IBA
10/2022 - 04/2005
11Peptides (Polypeptides)IBA
12/2021 - 05/2003
10Small Interfering RNA (siRNA)IBA
12/2020 - 08/2005
9Reactive Oxygen Species (Oxygen Radicals)IBA
01/2023 - 01/2014
9VaccinesIBA
01/2021 - 03/2002
8Interleukin-6 (Interleukin 6)IBA
09/2022 - 08/2014
8Glucose (Dextrose)FDA LinkGeneric
08/2022 - 03/2012
8Therapeutic UsesIBA
01/2022 - 01/2016
8SteroidsIBA
01/2022 - 09/2003
8Doxorubicin (Adriamycin)FDA LinkGeneric
01/2021 - 08/2005
8nephrinIBA
01/2014 - 11/2003
7RNA (Ribonucleic Acid)IBA
10/2022 - 04/2005
7Estrogen ReceptorsIBA
03/2022 - 03/2014
7Phosphotransferases (Kinase)IBA
01/2022 - 08/2013
7Complement System Proteins (Complement)IBA
01/2022 - 10/2010
7CreatinineIBA
01/2019 - 03/2012
7NPHS2 proteinIBA
12/2017 - 11/2003
6CholesterolIBA
10/2022 - 01/2019
6Immunoglobulin G (IgG)IBA
06/2022 - 01/2019
6EnzymesIBA
01/2022 - 03/2009
6LigandsIBA
01/2022 - 01/2012
6DecorinIBA
01/2021 - 05/2011
6Retinaldehyde (Retinal)IBA
01/2021 - 11/2010
6Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
07/2020 - 07/2005
6Collagen Type IV (Type IV Collagen)IBA
01/2020 - 04/2005
6Brain-Derived Neurotrophic Factor (BDNF)IBA
01/2020 - 03/2014
6AntigensIBA
11/2017 - 05/2003
5LipopolysaccharidesIBA
10/2022 - 05/2011
5Hormones (Hormone)IBA
08/2022 - 01/2019
568Ga-pentixaforIBA
08/2022 - 01/2019
5Untranslated RNA (Noncoding RNA)IBA
06/2022 - 06/2014
5salicylhydroxamic acid (SHAM)IBA
06/2022 - 01/2012
5LipidsIBA
04/2022 - 08/2010
5cyanoginosin LR (microcystin LR)IBA
04/2022 - 01/2019
5ChemokinesIBA
01/2022 - 10/2010
5Protein Isoforms (Isoforms)IBA
01/2022 - 09/2008
5Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2022 - 01/2012
5Transcription Factors (Transcription Factor)IBA
01/2021 - 07/2011
5Transforming Growth Factors (Transforming Growth Factor)IBA
01/2021 - 05/2011
5erucylphosphocholineIBA
12/2019 - 02/2015
5Puromycin AminonucleosideIBA
01/2016 - 04/2004
5melamineIBA
11/2011 - 03/2009
4HydrogelsIBA
01/2023 - 12/2020

Therapy/Procedure

66Therapeutics
08/2022 - 05/2004
17Drug Therapy (Chemotherapy)
08/2022 - 01/2006
9Transplantation
01/2020 - 03/2011
8Immunotherapy
01/2022 - 01/2009
7Length of Stay
01/2021 - 10/2011
5Lasers (Laser)
08/2022 - 11/2012
5Ligation
11/2021 - 06/2009